These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6671927)

  • 41. Trimethoprim/sulphamethoxazole resistance in Escherichia coli and Klebsiella spp. urinary isolates.
    Obaseiki-Ebor EE
    Afr J Med Med Sci; 1988 Sep; 17(3):175-9. PubMed ID: 2845759
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Susceptibility of anaerobic bacteria to sulfamethoxazole/trimethoprim and routine susceptibility testing.
    Wüst J; Wilkins TD
    Antimicrob Agents Chemother; 1978 Sep; 14(3):384-90. PubMed ID: 708016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Treatment of chancroid. A comparison of sulphamethoxazole and trimethoprim-sulphamethoxazole.
    Fast MV; Nsanze H; Plummer FA; D'Costa LJ; MacLean IW; Ronald AR
    Br J Vener Dis; 1983 Oct; 59(5):320-4. PubMed ID: 6351957
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Comparative activity of sulfamethoxazole-trimethoprim (SMZ-TMP) on bacteria responsible for ORL infections].
    Joly B; Sirot D; Cluzel M; Chanal M; Bruneau D
    Pathol Biol (Paris); 1984 Jun; 32(6):689-92. PubMed ID: 6611536
    [TBL] [Abstract][Full Text] [Related]  

  • 45. In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus.
    Yeldandi V; Strodtman R; Lentino JR
    J Antimicrob Chemother; 1988 Dec; 22(6):873-80. PubMed ID: 3266621
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of trimethoprim on the occurrence of drug-resistant coliform bacteria in the faecal flora.
    Toivanen A; Kasan A; Sundquist H; Toivanen P
    Chemotherapy; 1976; 22(2):97-103. PubMed ID: 1253636
    [TBL] [Abstract][Full Text] [Related]  

  • 47. High prevalence of antimicrobial resistance among Shigella isolates in the United States tested by the National Antimicrobial Resistance Monitoring System from 1999 to 2002.
    Sivapalasingam S; Nelson JM; Joyce K; Hoekstra M; Angulo FJ; Mintz ED
    Antimicrob Agents Chemother; 2006 Jan; 50(1):49-54. PubMed ID: 16377666
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Dissemination of Trimethoprim-Sulfamethoxazole Drug Resistance Genes Associated with Class 1 and Class 2 Integrons Among Gram-Negative Bacteria from HIV Patients in South India.
    Ramesh Kumar MR; Arunagirinathan N; Srivani S; Dhanasezhian A; Vijaykanth N; Manikandan N; Balakrishnan S; Vignesh R; Balakrishnan P; Solomon S; Solomon SS
    Microb Drug Resist; 2017 Jul; 23(5):602-608. PubMed ID: 27854149
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Sensitivity of enterobacteriaceae to sulfamethoxazole (SMZ), trimethoprim (TMP) and cotrimexazole (SMZ plus TMP)].
    Lynch B; Valenzuela MC; Donoso E; Cofre J; Vilches A; Aguero ME
    Rev Chil Pediatr; 1975; 46(1):17-9. PubMed ID: 1178944
    [No Abstract]   [Full Text] [Related]  

  • 50. A comparison of trimethorprim-sulfamethoxazole with sulfamethoxazole alone in infections localized to the kidneys.
    Harding GK; Ronald AR; Boutros P; Lank B
    Can Med Assoc J; 1975 Jun; 112(13 Spec No):9-12. PubMed ID: 1093658
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Trimethoprim/sulfametrole: evaluation of the available clinical and pharmacokinetic/pharmacodynamic evidence.
    Vouloumanou EK; Karageorgopoulos DE; Rafailidis PI; Michalopoulos A; Falagas ME
    Int J Antimicrob Agents; 2011 Sep; 38(3):197-216. PubMed ID: 21741802
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Anti-fungal activity of sulfamethoxazole toward Aspergillus species.
    Hida S; Yoshida M; Nakabayashi I; Miura NN; Adachi Y; Ohno N
    Biol Pharm Bull; 2005 May; 28(5):773-8. PubMed ID: 15863877
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Agar dilution susceptibility of Bacteroides spp. to sulfamethoxazole and trimethoprim: correlation with a disk diffusion technique.
    Riley TV
    Antimicrob Agents Chemother; 1981 Dec; 20(6):731-5. PubMed ID: 7325639
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Chronic granulomatous disease: effect of sulfamethoxazole/trimethoprim on neutrophil microbicidal function.
    Seger RA; Baumgartner S; Tiefenauer LX; Gmünder FK
    Helv Paediatr Acta; 1981; 36(6):579-88. PubMed ID: 7333866
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Poor rectal absorption of trimethoprim/sulphamethoxazole in treating Pneumocystis carinii pneumonia.
    Dorr RT; Powell JR; Heick M; Barry DW
    Postgrad Med J; 1981 Feb; 57(664):123-5. PubMed ID: 6973756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Treatment of gonorrhea with trimethoprim-sulfamethoxazole.
    Elliott WC; Reynolds G; Thornsberry C; Kellogg DS; Jaffe HW; Brown ST; Armstrong J; Rein MF
    J Infect Dis; 1977 Jun; 135(6):939-43. PubMed ID: 405433
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Incidence of trimethoprim-sulfamethoxazole-resistant enterobacteriaceae among transplant recipients.
    Wells CL; Podzorski RP; Peterson PK; Ramsay NK; Simmons RL; Rhame FS
    J Infect Dis; 1984 Nov; 150(5):699-706. PubMed ID: 6387000
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In-vitro susceptibility of the Bacteroides fragilis group and the inoculum effect of newer beta-lactam antibiotics on this group of organisms.
    Jacobus NV; Cuchural GJ; Tally FP
    J Antimicrob Chemother; 1989 Nov; 24(5):675-82. PubMed ID: 2599992
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antimicrobial resistance and resistance transfer in anaerobic. A review.
    Tally FP; Malamy MH
    Scand J Gastroenterol Suppl; 1984; 91():21-30. PubMed ID: 6377471
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment of Pneumocystis carinii pneumonia in patients with AIDS.
    Wordell CJ; Hauptman SP
    Clin Pharm; 1988 Jul; 7(7):514-27. PubMed ID: 3138063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.